Search PubMed⌕ Search

Biomedical subjects

I Lewis

Publications and source records attributed to I Lewis.

76 records · Page 5Linked to original sources

inheritance of sperm centrioles and centrosomes in bovine embryos.

Immature cumulus oocyte complexes (COCs) were aspirated from ovarian follicles of slaughtered cow and matured for 24 h in TCM 199 medium with hormones. Eighty-five percent of oocytes matured with subsequent abstriction of the polar body. Matured COCs were then inseminated with frozen-thawed semen (2 x 10(6)/mL final concentration). Eighteen hours after insemination, fertilized COCs were vortexed, washed, and cultured to the pronuclear stage and syngamy (24-36 h postinsemination) and fixed for TEM. Unfixed embryos achieved a cleavage rate of 54%, with 29% developing to blastocysts. Fertilization was confirmed by TEM. Examination of fertilized bipronuclear ova revealed the presence of a sperm aster associated with sperm midpieces, tails, and male pronuclei in several embryos. Further examination of embryos at syngamy showed centrioles at one pole of the first mitotic bipolar spindle in two embryos. Since the mature oocyte at metaphase II has no centrioles at spindly poles, this centriole was most likely derived from the sperm, which has a single proximal centriole associated with pericentriolar material in its neck region, like most mammalian sperm. Tripronuclear ova produced disorganized bipolar spindles or, rarely, tripolar spindles. Bovine embryos, too, follow Boveri's rule of paternal inheritance as in man and most animals. It is possible that both paternal centrosomes (centrioles) and maternal centrosomes are involved in the organization of bipolar spindles in these embryos, quite unlike the mouse embryo where maternal centrosomes seem to organize the first mitotic spindle. The bovine embryo appears to be an appropriate model to study centriolar inheritance.

Animals↗

Therapeutic efficacy of interleukin-2 activated killer cells against adriamycin resistant mouse B16-BL6 melanoma.

Development of multidrug-resistance (MDR) remains a major cause of failure in the treatment of cancer with chemotherapeutic agents. In our efforts to explore alternative treatment regimens for multidrug-resistant tumors we have examined the sensitivity of MDR tumor cell lines to lymphokine activated killer (LAK) cells. Adriamycin (ADM) resistant B16-BL6 melanoma, L1210 and P388 leukemic cell lines were tested for sensitivity to lysis by LAK cells in vitro. While ADM-resistant B16-BL6 and L1210 sublines were found to exhibit at least 2-fold greater susceptibility to lysis by LAK cells, sensitivity of ADM-resistant P388 cell was similar to that of parental cells. Since ADM-resistant B16-BL6 cells were efficiently lysed by LAK cells in vitro, the efficacy of therapy with LAK cells against the ADM-resistant B16-BL6 subline in vivo was evaluated. Compared to mice bearing parental B16-BL6 tumor cells, the adoptive transfer of LAK cells and rIL2 significantly reduced formation of experimental metastases (P less than 0.009) and extended median survival time (P less than 0.001) of mice bearing ADM-resistant B16-BL6 tumor cells. Results suggest that immunotherapy with LAK cells and rIL2 may be a useful modality in the treatment of cancers with the MDR phenotype.

Animals↗